News – Page 640 – Endpoints News

Bristol Myers wants to pull out of its Abraxane deal in China. BeiGene says no way

4 years ago

Covid-19 roundup: Regeneron nabs priority review for mAb; Preprint suggests mixing boosters is safe ahead of adcomms

4 years ago

Broad Institute hires René Salazar to tackle biomedical research's diversity problem

4 years ago

Atlas backs a longtime Vertex employee’s quest to bring CF success to numerous other diseases

4 years ago

Biden's fight with Moderna over providing vaccines for the poorest countries intensifies

4 years ago

Merck carves out path in first-line advanced cervical cancer with new FDA win for Keytruda juggernaut

4 years ago

FDA+ roundup: Marks on Woodcock's tenure as acting commissioner; FDA leaders offer perspective on barriers to ...

4 years ago

Big Pharma companies join hands with Amazon on new Israel-based AI incubator

4 years ago

Regulus dumps first-gen ADPKD treatment in favor of second iteration; Sutro joins BioNova in $200M deal

4 years ago

Charles River Laboratories has been on an acquisition spree. But Tuesday, it offloaded two assets

4 years ago

Spurned by the FDA, Ardelyx execs grab bonuses to stay on while axing nearly two-thirds of remaining staff

4 years ago

Eli Lilly bags FDA nod for Verzenio in early breast cancer, but a controversial diagnostic could dog its rollout

4 years ago

J&J proposes sliding booster timelines as FDA questions lack of data for Delta, older adults before adcomm

4 years ago

Drawn to the idea of turning B cells into 'protein factories,' Takeda jumps into a milestone-heavy, $900M pact

4 years ago

Treating autism through the gut? Axial Therapeutics refuels on its exploration of the gut-brain axis

4 years ago

FDA authorizes sale of e-cigarettes for the first time, shifting debate and drawing fire from critics

4 years ago

As TRIPS council meets, the IP waiver for vaccines is on life support ahead of a December deadline

4 years ago

Intellia enters Editas’ turf with ocular CRISPR pact

4 years ago

GSK tangoes with private equity players to explore $54B sale of consumer unit instead of IPO — report

4 years ago

CRISPR Therapeutics claims safety advantage in first big look at off-the-shelf CAR-T data, but durability in question

4 years ago

CureVac spins a major setback on their mRNA Covid vaccine into an advantage in the market wars to come

4 years ago

FDA still isn't really throwing its weight behind Covid-19 vaccine boosters, Moderna's adcomm briefing docs show

4 years ago

Inside the deal: As leaked details goosed its stock, Acceleron's CEO pumped Merck for more cash

4 years ago

Quiet CinCor Pharma makes some noise with $143M, new trial plans for blood pressure drug

4 years ago

First page Previous page 637 638 639640641 642 643 Next page Last page